ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Ponders Standards For “Retrospective Prospective” Studies

January 30, 2009

CMS Develops New Math of Medicare: Reimbursement Money for Outcomes Data.

February 4, 2005

In Brief: Simone, LoBuglio Lead AACI; AMA Honors B.J. Kennedy; FDA Meet Patient Advocates

July 31, 1992

NCI-Approved Clinical Trials

June 30, 2006

Clinical Research: Cooperative Groups Form Coalition to Advance Trials

November 14, 1997

Drug Shortages Reach All-Time High—Ben Venue Exit Will Make Problem Worse

October 11, 2013